Publikationen

Zahlreiche Veröffentlichungen in führenden medizinischen Fachzeitschriften

Unraveling the enigma of long COVID: novel aspects in pathogenesis, diagnosis, and treatment protocols
AM Baig, S Rosko, B Jaeger, J Gerlach, et al.
Inflammopharmacology . doi: 10.1007/s10787-024-01483-2
Case Report: Long Covid Patients Successfully Treated by Means of Heparin-Mediated Extracorporeal LDL Precipitation (HELP) Apheresis
BR Jaeger, HE Arron, RM Booyens, et al.
Infectious Diseases Diagnosis & Treatment
The potential of heparin-induced extracorporeal LDL/fibrinogen precipitation (HELP)-apheresis for patients with severe acute or chronic COVID-19
BR Jaeger, HE Arron, WM Kalka-Moll, et al.
Frontiers in Cardiovascular Medicine. doi: 10.3389/fcvm.2022.1007636/full
Rationale and design of MultiSELECt: A European Multicenter Study on the Effect of Lipoprotein (a) Elimination by lipoprotein apheresis on Cardiovascular outcomes
B Hohenstein, U Julius, P Lansberg, B Jaeger, et al.
Atherosclerosis Supplements
Cardiac allograft vasculopathy: microvascular arteriolar capillaries (‘capioles”) and survival
CA Labarrere, BR Jaeger, GS Kassab – Front Biosci, 2017
Frontiers in Bioscience
Postoperative heparin-mediated extracorporeal low-density lipoprotein fibrinogen precipitation aphaeresis prevents early graft occlusion after coronary artery bypass …
M Oberhoffer, S Eifert, B Jaeger, F Blessing, et al.
The Surgery Journal. doi: 10.1055/s-0036-1584167
Early inflammatory markers are independent predictors of cardiac allograft vasculopathy in heart-transplant recipients
CA Labarrere, JR Woods, JW Hardin, BR Jaeger, et al.
PLOS ONE. doi: 10.1371/journal.pone.0113260
Biomarkers of heart transplant rejection: the good, the bad, and the ugly!
CA Labarrere, BR Jaeger – Translational Research, 2012
Translational Research
Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein (a) levels and prevent major adverse coronary events
BR Jaeger, Y Richter, D Nagel, F Heigl, et al.
Nature Reviews Cardiology
Smoking cessation and subclinical atherosclerosis—results from the Heinz Nixdorf Recall Study
KH Jöckel, N Lehmann, BR Jaeger, S Moebus, et al.
Atherosclerosis
The German Lipid Apheresis Registry–remaining to be established
V Schettler, BR Jaeger, R Klingel, et al.
Atherosclerosis Supplements
Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery
M Thielmann, M Neuhäuser, A Marr, BR Jaeger, et al.
The Journal of Thoracic and Cardiovascular Surgery
Molecular identification and differentiation of Brevibacterium species and strains
TS Hoppe-Seyler, B Jaeger, W Bockelmann, et al.
Systematic and Applied Microbiology
Emergency re-revascularization with percutaneous coronary intervention, reoperation, or conservative treatment in patients with acute perioperative graft failure …
M Thielmann, P Massoudy, BR Jaeger, et al.
European Journal of Cardio-Thoracic Surgery
Changes in myocardial vasoreactivity after drastic reduction of plasma fibrinogen and cholesterol: a clinical study in long-term heart transplant survivors using positron …
BR Jaeger, FM Bengel, K Odaka, P Überfuhr, et al.
The Journal of Heart and Lung Transplantation
Heparin-mediated extracorporeal LDL precipitation treating a peripheral arterial disease patient suffering from repeated postoperative bypass occlusion
FJ Blessing, B Jaeger, Y Wang, AK Walli, D Seidel – Thrombosis research, 2005
Thrombosis Research
Fibrinogen and atherothrombosis: vulnerable plaque or vulnerable patient?
BR Jaeger, CA Labarrere – Herz, 2003
Herz. doi: 10.1007/s00059-003-2497-5
The HELP system for the treatment of atherothrombotic disorders: a review
BR Jaeger – Therapeutic Apheresis and Dialysis, 2003
Therapeutic Apheresis and Dialysis. doi: 10.1046/j.1526-0968.2003.00072.x
Long-term prevention of premature coronary atherosclerosis in homozygous familial hypercholesterolemia
BR Jaeger, T Tsobanelis, F Bengel, M Schwaiger, et al.
The Journal of Pediatrics
The influence of the brine microflora on the ripening of smear
B JAEGER, T Hoppe-Seyler, W Bockelmann, et al.
researchgate.net
Case Reports on Emergency Treatment of Cardiovascular Syndromes Through Heparin‐Mediated Low‐Density Lipoprotein/Fibrinogen Precipitation: A New …
BR Jaeger, E Kreuzer, A Knez, A Leber, et al.
Therapeutic Apheresis. doi: 10.1046/j.1526-0968.2002.00427.x
Evidence for maximal treatment of atherosclerosis: drastic reduction of cholesterol and fibrinogen restores vascular homeostasis
BR Jaeger – Therapeutic Apheresis, 2001
Therapeutic Apheresis. doi: 10.1111/j.1526-0968.2001.00289.x
Improvement of hemorheology by DALI apheresis: acute effects on plasma viscosity and erythrocyte aggregation in hypercholesterolemic patients
T Bosch, T Wendler, BR Jaeger, et al.
Therapeutic Apheresis. doi: 10.1046/j.1526-0968.2001.00368.x
Consistent lowering of clotting factors for the treatment of acute cardiovascular syndromes and hypercoagulability: a different pathophysiological approach
BR Jaeger, P Goehring, J Schirmer, et al.
Therapeutic Apheresis. doi: 10.1046/j.1526-0968.2001.00350.x
Increased Cerebral CO2 Reactivity After Heparin-Mediated Extracorporal LDL Precipitation (HELP) in Patients With Coronary Heart Disease and Hyperlipidemia
TK Pfefferkorn, HP Knüppel, BR Jaeger, J Thiery, et al.
Stroke. doi: 10.1161/01.str.30.9.1802
Heparin-Mediated Extracorporeal LDL/Fibrinogen Precipitation—HELP-In Coronary and Cerebral Ischemia
BR Jaeger, P Marx, T Pfefferkorn, G Hamann, et al.
Current Progress in the Understanding of Secondary Brain Damage from Trauma and Ischemia. doi: 10.1007/978-3-7091-6391-7_13
Coronary risk factor management for the prevention and treatment of graft vessel disease in heart transplant patients
BR Jaeger, J Schirmer, J Thiery, BM Meiser, et al.
Therapeutic Apheresis. doi: 10.1046/j.1526-0968.1999.00156.x
Aggressive lowering of fibrinogen and cholesterol in the prevention of graft vessel disease after heart transplantation
BR Jaeger, B Meiser, D Nagel, P Überfuhr, J Thiery, et al.
Circulation